Corbyn Investment Management’s Dun & Bradstreet DNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-346,181
Closed -$3.09M 64
2025
Q1
$3.09M Buy
346,181
+53,480
+18% +$547K 1.15% 30
2024
Q4
$3.65M Sell
292,701
-55
-0% -$658 1.31% 25
2024
Q3
$3.37M Sell
292,756
-12,628
-4% -$140K 1.29% 29
2024
Q2
$2.83M Sell
305,384
-75,946
-20% -$731K 1.17% 29
2024
Q1
$3.83M Buy
381,330
+87,785
+30% +$958K 1.69% 21
2023
Q4
$3.43M Sell
293,545
-2,854
-1% -$29.1K 1.62% 25
2023
Q3
$2.96M Buy
296,399
+51,379
+21% +$568K 1.51% 26
2023
Q2
$2.83M Sell
245,020
-9,356
-4% -$102K 1.37% 24
2023
Q1
$2.99M Buy
254,376
+1,297
+0.5% +$16.4K 1.2% 29
2022
Q4
$3.1M Buy
253,079
+74,855
+42% +$960K 1.23% 30
2022
Q3
$2.21M Buy
178,224
+273
+0.2% +$4.05K 0.94% 32
2022
Q2
$2.67M Sell
177,951
-1,816
-1% -$29.3K 1.08% 30
2022
Q1
$3.15M Sell
179,767
-1,360
-0.8% -$25.3K 1.03% 32
2021
Q4
$3.71M Sell
181,127
-142
-0.1% -$2.7K 1.12% 29
2021
Q3
$3.05M Buy
+181,269
New +$3.45M 1% 32

Other funds holding DNB

Corbyn Investment Management's DNB Position: Q2 2025 in Review

Corbyn Investment Management sold out of Dun & Bradstreet (DNB) in Q2 2025, closing a stake of 346,181 shares — an estimated $3.09M sold.

Corbyn Investment Management first reported a position in DNB in Q3 2021 and held it in 15 quarters. The position peaked at $3.83M in Q1 2024. 274 funds tracked by Wall St. Rank hold DNB as of Q2 2025.

  • Corbyn Investment Management reported no remaining Dun & Bradstreet position as of Q2 2025 after selling out during the quarter.
  • Corbyn Investment Management sold 346,181 Dun & Bradstreet shares in Q2 2025, an estimated $3.09M.
  • Corbyn Investment Management first reported a position in Dun & Bradstreet in Q3 2021 and held it in 15 quarters.
  • Corbyn Investment Management's Dun & Bradstreet position peaked at $3.83M in Q1 2024.
  • 274 funds tracked by Wall St. Rank held Dun & Bradstreet as of Q2 2025.

Based on Corbyn Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.